Brief: Bone Biologics Provides Scientific Update On Nb1 Bone Graft Device
26/09/2023 13:09
Sept 26 (Reuters) - Bone Biologics Corp BBLG.O :
* BONE BIOLOGICS PROVIDES SCIENTIFIC UPDATE ON NB1 BONE
GRAFT
DEVICE
* BONE BIOLOGICS CORP - 30-PATIENT PILOT STUDY IS EXPECTED
TO BE
CONDUCTED IN AUSTRALIA
Source text for Eikon: ID:nBw40MWx6a
Further company coverage: BBLG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bone Biologics
See all newsBone Biologics Corp expected to post a loss of 39 cents a share - Earnings Preview
Brief: Bone Biologics Extends Rhnell-1 Shelf Life To 24 Months
Brief: Bone Biologics CEO Issues Letter To Stockholders Highlighting Company Update And Outlook
Bone Biologics Corp expected to post a loss of 53 cents a share - Earnings Preview
Bone Biologics Corp expected to post a loss of 58 cents a share - Earnings Preview